Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 16, Number 6—June 2010
Dispatch

Variations in Human Herpesvirus Type 8 Seroprevalence in Native Americans, South America

Vanda A.U.F. Souza, Francisco M. Salzano, Maria Luiza Petzl-Erler, Maria Claudia Nascimento, Philippe Mayaud, Jaila Dias Borges, and Claudio S. PannutiComments to Author 
Author affiliations: Universidade de São Paulo, São Paulo, Brazil (V.A.U.F. Souza, C.S. Pannuti, M.C. Nascimento, J.D. Borges); Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil (F.M. Salzano); Universidade Federal do Paraná, Curitiba, Brazil (M.L. Petzl-Erler); London School of Hygiene and Tropical Medicine, London, UK (M.C. Nascimento, P. Mayaud).

Main Article

Table 1

Prevalence of HHV-8 antibodies in Amazonian and non-Amazonian Native American populations, by assay type*

Population, locality†
No. persons tested
No. (%) persons HHV-8 seropositive
By IFA-LANA or IFA-lytic
By IFA-LANA
By IFA-lytic
By IFA-LANA and IFA-lytic
Wai-Wai, Mapuera, Brazil 530 397 (75) 372 (70) 204 (38) 177 (33)
Xikrin, Caeteté, Brazil 30 15 (50) 13 (43) 6 (20) 4 (13)
Gorotire, PI Gorotire, Brazil 30 20 (67) 20 (67) 7 (23) 7 (23)
Kuben-Kran-Kegn, Nilo Peçanha, Brazil 30 25 (83) 25 (83) 4 (13) 4 (13)
Krahó, Cachoeira, Brazil 20 12 (60) 10 (50) 10 (50) 7 (35)
Ayoreo,Tobité, Bolivia 18 5 (28) 5 (28) 2 (11) 2 (11)
Ayoreo, Pozo Verde, Bolivia 17 3 (18) 2 (12) 1 (6) 0 (0)
Ayoreo, M Auxiliadora, Paraguay 20 9 (45) 9 (45) 7 (35) 7 (35)
Kaingang, Ivaí, Brazil 30 0 0 0 0
Kaingang, Rio das Cobras, Brazil 26 0 0 0 0
Guarani, Rio das Cobras, Brazil 29 4 (14) 4 (14) 2 (7) 2 (7)

*HHV-8, human herpesvirus type 8; IFA, immunofluorescence assay; LANA, latency-associated nuclear antigen.
†Listed in a north–south gradient (Figure).

Main Article

Page created: February 07, 2011
Page updated: February 07, 2011
Page reviewed: February 07, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external